drugset / Trial / NCT04357522
Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate Immunogenicity and safety of 15-Valent Pneumococcal Conjugate Vaccine in healthy volunteers aged 2 and 3 months.
Timeline
- Start
- 2020-07
- Primary completion
- 2026-03
- Completion
- 2026-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 15-Valent Pneumococcal Conjugate Vaccine | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Prevnar 13 | Vaccine | 0.5 ml | Intramuscular |